Vidarabine (Vira-A).
D002986:Clinical Trials as Topic; D006801:Humans; D007635:Keratitis, Dendritic / Q000188:drug therapy*; D014740:Vidarabine / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*
D014740:Vidarabine